Main Street Financial Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-434
| Closed | -$210K | – | 564 |
|
|
2025
Q1 | $210K | Buy |
+434
| New | +$210K | 0.02% | 475 |
|
|
2024
Q3 | – | Sell |
-2,699
| Closed | -$1.27M | – | 557 |
|
|
2024
Q2 | $1.27M | Buy |
2,699
+381
| +16% | +$179K | 0.12% | 158 |
|
|
2024
Q1 | $969K | Buy |
+2,318
| New | +$969K | 0.1% | 187 |
|
|
2023
Q4 | – | Sell |
-596
| Closed | -$207K | – | 475 |
|
|
2023
Q3 | $207K | Buy |
596
+11
| +2% | +$3.83K | 0.03% | 426 |
|
|
2023
Q2 | $206K | Buy |
+585
| New | +$206K | 0.03% | 423 |
|
|
2022
Q2 | – | Sell |
-3,691
| Closed | -$963K | – | 498 |
|
|
2022
Q1 | $963K | Buy |
3,691
+64
| +2% | +$16.7K | 0.14% | 152 |
|
|
2021
Q4 | $796K | Buy |
3,627
+1,616
| +80% | +$355K | 0.11% | 179 |
|
|
2021
Q3 | $365K | Buy |
2,011
+105
| +6% | +$19.1K | 0.06% | 321 |
|
|
2021
Q2 | $384K | Buy |
1,906
+666
| +54% | +$134K | 0.06% | 298 |
|
|
2021
Q1 | $266K | Sell |
1,240
-274
| -18% | -$58.8K | 0.05% | 349 |
|
|
2020
Q4 | $358K | Buy |
+1,514
| New | +$358K | 0.07% | 256 |
|